SLS - SELLAS Life Sciences Group, Inc.
IEX Last Trade
0.92
0.013 1.457%
Share volume: 1,190,446
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.91
-0.03
-0.03%
Summary score
8%
Profitability
8%
Dept financing
13%
Liquidity
38%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-88.33%
Return on assets
-24.4%
Return on sales
-291.54%
Return on invested capital
39.22%
Total debt ratio
48.17%
Debt ratio change over timeo
-0.79%
Current Ratio
3.13%
Quick Ratio
3.35%
Cash Position Ratio
2.78%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-33.56%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
50.2%
Debt ratio change over timeo
-0.32%
Current Ratio
1.88%
Quick Ratio
0%
Cash Position Ratio
1.63%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-39.47%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
60.37%
Debt ratio change over time
-0.18%
Current Ratio
1.49%
Quick Ratio
0%
Cash Position Ratio
1.28%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-140.21%
Return on assets
-115.41%
Return on sales
-114.85%
Return on invested capital
-54.16%
Total debt ratio
-79.27%
Debt ratio change over time
-0.79%
Current Ratio
-0.59%
Quick Ratio
-0.98%
Cash Position Ratio
-0.63%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SLS | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -88.33% | 13.03% | 18.15% | 6.63% |
| Return on assets | -24.4% | 2.28% | 3.22% | 5.84% |
| Return on sales | -291.54% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | 39.22% | 2.07% | 5.53% | 34.89% |
| Profitability | 25% | 45% | 60% | 81% |
| Total debt ratio | 48.17% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | -0.79% | 435.59% | 17.23% | -0.06% |
| Dept financing | 13% | 50% | 26% | 7% |
| Current Ratio | 1.88% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 1.63% | 0.31% | 0.49% | 2.77% |
| Liquididy | 61% | 12% | 27% | 75% |
| Short-term ratios | SLS | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 5.91% |
| Return on assets | -33.56% | 1.6% | 2.14% | 4.97% |
| Return on sales | 0% | 24.8% | 18.91% | 42.59% |
| Return on invested capital | 0% | 0% | 0% | 23.7% |
| Profitability | 0% | 23% | 22% | 100% |
| Total debt ratio | 50.2% | 94.49% | 93.35% | 24.56% |
| Debt ratio change over time | -0.32% | 0% | 0% | -0.62% |
| Dept financing | 13% | 25% | 50% | 6% |
| Current Ratio | 1.88% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 1.63% | 0.31% | 0.49% | 2.77% |
| Liquididy | 28% | 14% | 21% | 75% |